Table 3. Fractional Allelic Loss (FAL) describing the number of loss events over the total number of informative events for a sample per cohort.
Feature | N | BRAF mut/MSS Av Fractional Allelic Loss | P Value | N | BRAF wt/MSS Av Fractional Allelic Loss | P Value | P Value between cohorts |
Overall | 56 | 0.304 | – | 90 | 0.386 | – | 0.1 |
AJCC Stage I+ II | 13 | 0.132 | 0.01 | 37 | 0.396 | 0.82 | 0.005 |
AJCC St. III + IV | 16 | 0.362 | 33 | 0.412 | 0.55 | ||
AJCC Stage I | 2 | 0.100 | 0.03 | 11 | 0.347 | 0.92 | 0.36 |
AJCC Stage II | 11 | 0.138 | 26 | 0.417 | 0.006 | ||
AJCC Stage III | 10 | 0.283 | 20 | 0.415 | 0.28 | ||
AJCC Stage IV | 6 | 0.492 | 13 | 0.407 | 0.44 | ||
Proximal Loc. | 30 | 0.333 | 0.91 | 25 | 0.325 | 0.19 | 0.92 |
Distal Location | 15 | 0.323 | 57 | 0.416 | 0.25 | ||
Female Gender | 28 | 0.225 | 0.04 | 39 | 0.392 | 0.86 | 0.02 |
Male Gender | 28 | 0.383 | 51 | 0.381 | 0.98 | ||
P53 Mutant * | 20 | 0.375 | 0.17 | 42 | 0.491 | <0.001 | 0.14 |
P53 Wild Type * | 36 | 0.260 | 48 | 0.274 | 0.83 | ||
CIMP High | 24 | 0.240 | 0.35 | 3 | 0.444 | 0.81 | 0.26 |
CIMP Low/Nil | 20 | 0.321 | 76 | 0.404 | 0.29 | ||
Kras Mutant | – | – | – | 41 | 0.320 | 0.045 | – |
Kras Wild Type | – | – | 49 | 0.441 |
Average FAL and corresponding p53 mutational status was analysed using CIN data at the 5q, 8p and 18q loci only.